NCT02099669.

Trial name or title	Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC): a pilot, feasibility Study
Methods	Randomised clinical trial
Participants	All participants with MDS ≥18 years of age, transfusion dependent: at least 1 transfusion per month in the last 8 weeks, haemoglobin < 10 g/dL
Interventions	Liberal transfusion strategy: to maintain Hb level between 11 g/dL and 12 g/dL Restrictive transfusion strategy: to maintain Hb level between 8.5 g/dL and 10 g/dL
Outcomes	Percentage compliance of q2weekly haemoglobin
Starting date	March 2014
Contact information	Kristina Commisso kristina.commisso@sunnybrook.ca
Notes	‐